Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-20-003029
Filing Date
2020-05-26
Accepted
2020-05-22 21:59:04
Documents
58
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q imle_10q.htm 10-Q 572614
2 ASSET PURCHASE AGREEMENT imle_ex1012.htm EX-10.12 18359
3 CERTIFICATION imle_ex311.htm EX-31.1 10340
4 CERTIFICATION imle_ex312.htm EX-31.2 10406
5 CERTIFICATION imle_ex321.htm EX-32.1 3847
6 CERTIFICATION imle_ex322.htm EX-32.2 3841
  Complete submission text file 0001477932-20-003029.txt   4184847

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT imle-20200331.xml EX-101.INS 694012
8 XBRL TAXONOMY EXTENSION SCHEMA imle-20200331.xsd EX-101.SCH 72724
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE imle-20200331_lab.xml EX-101.LAB 353478
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE imle-20200331_cal.xml EX-101.CAL 41676
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imle-20200331_pre.xml EX-101.PRE 335902
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE imle-20200331_def.xml EX-101.DEF 273795
Mailing Address 885 ARAPAHOE ROAD BOULDER CO 80302
Business Address 885 ARAPAHOE ROAD BOULDER CO 80302 303-443-4430
TransBiotec, Inc. (Filer) CIK: 0001425627 (see all company filings)

EIN.: 260731818 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-53316 | Film No.: 20907801
SIC: 2721 Periodicals: Publishing or Publishing & Printing